GeoVax Labs, Inc. (GOVX): Total Assets
$6.34M
As of 2025-12-31
$4.64M
As of 2026-06-30
-41.3%
3-year compound annual growth
-9.4%
5-year compound annual growth
+16.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.34M | -22.2% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $8.16M | -12.1% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $9.28M | -70.4% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $31.35M | +165.7% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $11.80M | +13.5% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $10.39M | n/m | 2022-03-09, Balance as of period end |
| 2019-12-31 | $468.9K | -27.0% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $642.1K | +31.0% | 2020-03-24, Balance as of period end |
| 2017-12-31 | $490.2K | -19.7% | 2019-03-26, Balance as of period end |
| 2016-12-31 | $610.2K | -54.2% | 2018-03-23, Balance as of period end |
| 2015-12-31 | $1.33M | -0.1% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $1.33M | -53.0% | 2016-03-16, Balance as of period end |
| 2013-12-31 | $2.84M | +92.1% | 2015-03-20, Balance as of period end |
| 2012-12-31 | $1.48M | -10.2% | 2014-03-14, Balance as of period end |
| 2011-12-31 | $1.65M | -30.2% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $2.36M | n/a | 2012-03-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $6.34M | -22.2% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $296.41M | -31.9% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $353.77M | -26.6% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $37.66M | -3.0% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $530.92M | +42.0% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $17.01M | -24.5% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $422.5K | +50.3% |
Compare GOVX, RNAC, UPB, XBIO side by side · Screen every company in Pharmaceutical Preparations ↗